Avenda Health wins FDA breakthrough nod for AI-based prostate cancer treatment

Avenda Health announced today that it received FDA breakthrough device designation for its AI-based male “lumpectomy” product.

Santa Monica. Calif.-based Avenda designed its lumpectomy product to treat prostate cancer in-office while preserving the quality of life through AI and minimally invasive technologies, according to a news release.

Read the full article here. 

Source: Mass Device